» Articles » PMID: 23143525

Precise Determination of Time to Reach Viral Load Set Point After Acute HIV-1 Infection

Overview
Date 2012 Nov 13
PMID 23143525
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The HIV viral load set point has long been used as a prognostic marker of disease progression and more recently as an end-point parameter in HIV vaccine clinical trials. The definition of set point, however, is variable. Moreover, the earliest time at which the set point is reached after the onset of infection has never been clearly defined.

Methods: In this study, we obtained sequential plasma viral load data from 60 acutely HIV-infected Chinese patients among a cohort of men who have sex with men, mathematically determined viral load set point levels, and estimated time to attain set point after infection. We also compared the results derived from our models and that obtained from an empirical method.

Results: With novel uncomplicated mathematic model, we discovered that set points may vary from 21 to 119 days dependent on the patients' initial viral load trajectory. The viral load set points were 4.28 ± 0.86 and 4.25 ± 0.87 log10 copies per milliliter (P = 0.08), respectively, as determined by our model and an empirical method, suggesting an excellent agreement between the old and new methods.

Conclusions: We provide a novel method to estimate viral load set point at the very early stage of HIV infection. Application of this model can accurately and reliably determine the set point, thus providing a new tool for physicians to better monitor early intervention strategies in acutely infected patients and scientists to rationally design preventative vaccine studies.

Citing Articles

Study on the Technical Parameters for Estimating HIV-1 Incidence by Using a Recombinant Antigen-based Capture Enzyme Immunoassay - China.

Liang W, Wang J, Yan H, Zhang X, Dorjiwangmo , Li D China CDC Wkly. 2024; 6(48):1278-1282.

PMID: 39698327 PMC: 11649990. DOI: 10.46234/ccdcw2024.255.


Initial HIV-1 viral load in French Guiana: Factors associated with viral load set point differences.

Lucarelli A, Rabier S, Vergeade F, El Guedj M, Vaz T, Cisse H IJID Reg. 2024; 13:100487.

PMID: 39691355 PMC: 11650126. DOI: 10.1016/j.ijregi.2024.100487.


Increased HBV Coinfection and Decreased IFN-γ-Producing HBV-Specific CD8+ T Cell Numbers During HIV Disease Progression.

Zhu Z, Qin Y, Liang Q, Xia W, Zhang T, Wang W Front Immunol. 2022; 13:861804.

PMID: 35432386 PMC: 9005981. DOI: 10.3389/fimmu.2022.861804.


Analysis of the Characteristics of TIGIT-Expressing CD3CD56NK Cells in Controlling Different Stages of HIV-1 Infection.

Zhang X, Lu X, Cheung A, Zhang Q, Liu Z, Li Z Front Immunol. 2021; 12:602492.

PMID: 33717085 PMC: 7953050. DOI: 10.3389/fimmu.2021.602492.


Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV.

Powell A, Ren Y, Korom M, Saunders D, Hanley P, Goldstein H Mol Ther Methods Clin Dev. 2020; 19:78-88.

PMID: 33005704 PMC: 7508916. DOI: 10.1016/j.omtm.2020.08.015.


References
1.
Bland J, Altman D . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1(8476):307-10. View

2.
Schacker T, Collier A, Hughes J, Shea T, Corey L . Clinical and epidemiologic features of primary HIV infection. Ann Intern Med. 1996; 125(4):257-64. DOI: 10.7326/0003-4819-125-4-199608150-00001. View

3.
Mellors J, Munoz A, Giorgi J, Margolick J, Tassoni C, Gupta P . Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997; 126(12):946-54. DOI: 10.7326/0003-4819-126-12-199706150-00003. View

4.
Pedersen C, Katzenstein T, Nielsen C, Lundgren J, Gerstoft J . Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 16(2):93-9. DOI: 10.1097/00042560-199710010-00004. View

5.
Achhra A, Zhou J, Dabis F, Pujari S, Thiebaut R, Law M . Difference in absolute CD4+ count according to CD4 percentage between Asian and Caucasian HIV-infected patients. J AIDS Clin Res. 2011; 1(1):1-4. PMC: 3071513. DOI: 10.4172/2155-6113.1000101. View